These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19104916)

  • 1. Effect of ions on agitation- and temperature-induced aggregation reactions of antibodies.
    Fesinmeyer RM; Hogan S; Saluja A; Brych SR; Kras E; Narhi LO; Brems DN; Gokarn YR
    Pharm Res; 2009 Apr; 26(4):903-13. PubMed ID: 19104916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution.
    Thirumangalathu R; Krishnan S; Ricci MS; Brems DN; Randolph TW; Carpenter JF
    J Pharm Sci; 2009 Sep; 98(9):3167-81. PubMed ID: 19360857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies.
    Thakkar SV; Joshi SB; Jones ME; Sathish HA; Bishop SM; Volkin DB; Middaugh CR
    J Pharm Sci; 2012 Sep; 101(9):3062-77. PubMed ID: 22581714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of arginine glutamate on the stability of monoclonal antibodies in solution.
    Kheddo P; Tracka M; Armer J; Dearman RJ; Uddin S; van der Walle CF; Golovanov AP
    Int J Pharm; 2014 Oct; 473(1-2):126-33. PubMed ID: 24992318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonic rheology of a monoclonal antibody (IgG2) solution: implications for physical stability of proteins in high concentration formulations.
    Saluja A; Badkar AV; Zeng DL; Kalonia DS
    J Pharm Sci; 2007 Dec; 96(12):3181-95. PubMed ID: 17588261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta-cyclodextrin.
    Serno T; Carpenter JF; Randolph TW; Winter G
    J Pharm Sci; 2010 Mar; 99(3):1193-206. PubMed ID: 19774651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the Agitation-Induced Aggregation of Monoclonal Antibodies Using Surface Tensiometry.
    Shieh IC; Patel AR
    Mol Pharm; 2015 Sep; 12(9):3184-93. PubMed ID: 26198590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Throughput Prediction Approach for Monoclonal Antibody Aggregation at High Concentration.
    Zidar M; Šušterič A; Ravnik M; Kuzman D
    Pharm Res; 2017 Sep; 34(9):1831-1839. PubMed ID: 28593474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studies.
    Banks DD; Latypov RF; Ketchem RR; Woodard J; Scavezze JL; Siska CC; Razinkov VI
    J Pharm Sci; 2012 Aug; 101(8):2720-32. PubMed ID: 22648863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agitation-induced aggregation and subvisible particulate formation in model proteins.
    Jayaraman M; Buck PM; Ignatius AA; King KR; Wang W
    Eur J Pharm Biopharm; 2014 Jul; 87(2):299-309. PubMed ID: 24462794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental Model System to Study pH Shift-Induced Aggregation of Monoclonal Antibodies Under Controlled Conditions.
    Oyetayo OO; Kiefer H
    Pharm Res; 2016 Jun; 33(6):1359-69. PubMed ID: 26928669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb.
    Ghazvini S; Kalonia C; Volkin DB; Dhar P
    J Pharm Sci; 2016 May; 105(5):1643-1656. PubMed ID: 27025981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.
    Telikepalli SN; Kumru OS; Kalonia C; Esfandiary R; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2014 Mar; 103(3):796-809. PubMed ID: 24452866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysorbate 20 prevents the precipitation of a monoclonal antibody during shear.
    Patapoff TW; Esue O
    Pharm Dev Technol; 2009; 14(6):659-64. PubMed ID: 19883255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ionic strength affects tertiary structure and aggregation propensity of a monoclonal antibody adsorbed to silicone oil-water interfaces.
    Gerhardt A; Bonam K; Bee JS; Carpenter JF; Randolph TW
    J Pharm Sci; 2013 Feb; 102(2):429-40. PubMed ID: 23212809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies.
    Thakkar SV; Sahni N; Joshi SB; Kerwin BA; He F; Volkin DB; Middaugh CR
    Protein Sci; 2013 Oct; 22(10):1295-305. PubMed ID: 23893936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies.
    Majumder S; Jones MT; Kimmel M; Alphonse Ignatius A
    Pharm Res; 2018 Sep; 35(11):220. PubMed ID: 30255351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetate- and Citrate-Specific Ion Effects on Unfolding and Temperature-Dependent Aggregation Rates of Anti-Streptavidin IgG1.
    Barnett GV; Razinkov VI; Kerwin BA; Hillsley A; Roberts CJ
    J Pharm Sci; 2016 Mar; 105(3):1066-73. PubMed ID: 26886346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ReFOLD assay for protein formulation studies and prediction of protein aggregation during long-term storage.
    Svilenov H; Winter G
    Eur J Pharm Biopharm; 2019 Apr; 137():131-139. PubMed ID: 30818009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local dynamics and their alteration by excipients modulate the global conformational stability of an lgG1 monoclonal antibody.
    Thakkar SV; Kim JH; Samra HS; Sathish HA; Bishop SM; Joshi SB; Volkin DB; Middaugh CR
    J Pharm Sci; 2012 Dec; 101(12):4444-57. PubMed ID: 23060088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.